Role of the CMC Regulatory Strategist in Due Diligence

| 01 July 2009

A pharmaceutical or biologic due diligence exercise is a matchmaking process between two companies. It is undertaken to explore a potential deal driven by one company's need for another's medicinal product, medical device or technology, or in some cases, the other company in its entirety.

 

© 2022 Regulatory Affairs Professionals Society.

Discover more of what matters to you

No taxonomy